Home · Stock · VCYT

VCYT Veracyte Inc

Which ETFs hold VCYT? Veracyte Inc is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 9 Oct 2026
HealthcareDiagnostics & Research
$43.60
+25.3% 1y
$29.4552-week range$60.91
Market cap
$3.7B
P/E
31.1
3-month
-23.5%
CEO
Mr. Marc A. Stapley
Revenue · last 4 qtrs (+15.5% YoY)

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Provider

Currently Held By

ARK
ARKG
ARK Genomic Revolution ETF
Weight in fund3.30%
Shares held1,553,681
Market value$67.7M
View fund →
ARK
ARKK
ARK Innovation ETF
Weight in fund0.97%
Shares held1,530,111
Market value$66.7M
View fund →
Not held by the selected provider.

Insider Activity i

last 90 days
No notable insider activity in the last 90 days. Show all 1 trades
Net flow (90d):−$161K·0 BUY / 1 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
21 Sep 2026
John Leite
Global Chief Commercial Officer		SELLUnknown4,015$161K0
Showing all 1 tradesShow only significant
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic

Trade History

25 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
7 Oct 2026ARKGBUYAdded+389,516+0.84%24.62%
6 Oct 2026ARKGBUYAdded+115,462+0.21%9.53%
2 Oct 2026ARKKBUYAdded+159,319+0.05%7.91%
1 Oct 2026ARKKBUYAdded+76,362+0.05%4.58%
30 Sep 2026ARKKBUYAdded+119,449+0.08%7.74%
24 Sep 2026ARKGBUYAdded+20,905+0.13%2.01%
23 Sep 2026ARKGBUYAdded+12,579+0.08%1.18%
22 Sep 2026ARKGBUYAdded+74,881+0.21%7.23%
8 Sep 2026ARKKBUYAdded+22,148-0.02%1.80%
1 Sep 2026ARKGBUYAdded+7,031+0.02%0.72%
31 Aug 2026ARKKBUYAdded+161,228+0.11%13.61%
31 Aug 2026ARKGBUYAdded+51,841+0.11%5.34%
28 Aug 2026ARKKBUYAdded+36,111+0.02%3.49%
28 Aug 2026ARKGBUYAdded+11,678+0.06%1.27%
29 Jul 2026ARKKSELLReduced-20,521-0.05%1.97%
9 Jul 2026ARKGSELLReduced-67,470-0.18%7.34%
8 Jul 2026ARKGSELLReduced-12,424-0.07%1.32%
2 Jul 2026ARKKSELLReduced-55,680-0.05%4.81%
1 Jul 2026ARKKSELLReduced-53,991-0.11%4.53%
16 Jun 2026ARKKSELLReduced-166,229-0.16%10.94%
15 Jun 2026ARKKSELLReduced-62,701-0.05%2.18%
12 Jun 2026ARKKSELLReduced-55,081-0.07%2.90%
11 Jun 2026ARKKSELLReduced-143,289-0.09%8.17%
5 Jun 2026ARKKSELLReduced-28,496-0.01%1.65%
4 Jun 2026ARKKSELLReduced-112,072-0.03%6.14%
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds